-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Rubius Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2022.
- Rubius Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2022 was -$23.1M, a 57% increase year-over-year.
- Rubius Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2022 was -$178M, a 8.31% increase year-over-year.
- Rubius Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$178M, a 8.31% increase from 2021.
- Rubius Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$195M, a 16.9% decline from 2020.
- Rubius Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$166M, a 1.86% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)